Tetracaine Eye Drops as a Preemptive Topical Skin Anesthesia for Botulinum Toxin Type A Injections in Blepharospasm Patients: A Randomized Controlled Trial
Open Access
- 1 May 2026
- journal article
- clinical trial-report
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 20, 1-8
Abstract
Purpose: To evaluate the efficacy and safety of topical tetracaine eye drops as a preemptive skin anesthetic during botulinum toxin type A injection in blepharospasm patients. Patients and Methods: A double-blind, split-face randomized controlled trial was conducted in 17 participants diagnosed with benign essential blepharospasm between November 2023 and July 2024. Each patient received randomized treatment on opposite sides of the face: a cotton pad soaked with 5 mL of 0.5% tetracaine ophthalmic solution on one side and normal saline solution on the other, for 30 minutes. The cotton pad temperature, the injection dose, and the techniques were controlled on each side. A single neuro-ophthalmologist performed the injection. Pain scores were immediately rated after the injection, using a numeric rating scale from 0 to 10. Jankovic rating scale and complications were assessed on the day of injection, then 1 month and 3 months after injection. Results: The numeric rating scale on the side receiving topical 0.5% tetracaine eye drops was significantly lower than the side receiving topical normal saline solution (4.56 ± 2.63 vs 6.71 ± 2.54, p = 0.013). There were no significant differences in the Jankovic rating scale, cotton pad temperature, bleeding at the injection site, and other complications between the two groups. Conclusion: The application of 0.5% tetracaine ophthalmic solution as a preemptive topical skin anesthesia can decrease pain during botulinum toxin type A injection for blepharospasm patients without affecting the efficacy or producing any significant complications.Keywords
This publication has 27 references indexed in Scilit:
- Botulinum toxin therapy: reduction of injection site pain by pH normalisationJournal of Neural Transmission, 2016
- Vibration Anesthesia for the Reduction of Pain with Facial Dermal Filler InjectionsAesthetic Plastic Surgery, 2014
- Long-Term Efficacy of Botulinum A Toxin for Blepharospasm and Hemifacial SpasmCanadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 2010
- Easing Botox administration with EMLA creamAesthetic Surgery Journal, 2004
- Buffering the pain of local anaesthetics: A systematic reviewEmergency Medicine, 2003
- Indications and Limitations for the Use of Botulinum Toxin for the Treatment of Facial WrinklesAesthetic Plastic Surgery, 2002
- Chemical Injury to the Eye from EMLA Cream During Erbium Laser ResurfacingDermatologic Surgery, 1999
- The effects of EMLA and a topical formulation of 4%amethocaine (Ametop) on pain associated with retrobulbar injectionAnaesthesia, 1999
- Botulinum-A toxin in the treatment of craniocervical muscle spasms: Short- and long-term, local and systemic effectsSurvey of Ophthalmology, 1996
- Botulinum A toxin (Oculinum®) in ophthalmologySurvey of Ophthalmology, 1991